DK0510913T3 - Farmaceutiske sammensætninger indeholdende calcitonin - Google Patents

Farmaceutiske sammensætninger indeholdende calcitonin

Info

Publication number
DK0510913T3
DK0510913T3 DK92303554T DK92303554T DK0510913T3 DK 0510913 T3 DK0510913 T3 DK 0510913T3 DK 92303554 T DK92303554 T DK 92303554T DK 92303554 T DK92303554 T DK 92303554T DK 0510913 T3 DK0510913 T3 DK 0510913T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
containing calcitonin
calcitonin
calcium deficiency
Prior art date
Application number
DK92303554T
Other languages
Danish (da)
English (en)
Inventor
Tudor Arvinte
Amelia Cudd
Judith Phillips
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0510913T3 publication Critical patent/DK0510913T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK92303554T 1991-04-23 1992-04-21 Farmaceutiske sammensætninger indeholdende calcitonin DK0510913T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK0510913T3 true DK0510913T3 (da) 2000-10-16

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92303554T DK0510913T3 (da) 1991-04-23 1992-04-21 Farmaceutiske sammensætninger indeholdende calcitonin

Country Status (19)

Country Link
US (1) US5593962A (fr)
EP (1) EP0510913B1 (fr)
JP (1) JP3532580B2 (fr)
KR (1) KR100245534B1 (fr)
AT (1) ATE194775T1 (fr)
AU (1) AU653395B2 (fr)
CA (1) CA2066532C (fr)
CY (1) CY2246B1 (fr)
DE (1) DE69231263T2 (fr)
DK (1) DK0510913T3 (fr)
ES (1) ES2150418T3 (fr)
GB (1) GB9108634D0 (fr)
GR (1) GR3034414T3 (fr)
IE (1) IE921278A1 (fr)
IL (1) IL101622A (fr)
MX (1) MX9201825A (fr)
NZ (1) NZ242440A (fr)
PT (1) PT510913E (fr)
ZA (1) ZA922899B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
AU3556400A (en) 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
WO2001056594A1 (fr) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Formulations de calcitonine pour administration par voie nasale
RS20050247A (en) * 2002-09-27 2007-06-04 Zentaris Gmbh., Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
US20110034385A1 (en) * 2008-04-07 2011-02-10 National Institute Of Immunology Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
CA2066532A1 (fr) 1992-10-24
EP0510913B1 (fr) 2000-07-19
DE69231263D1 (de) 2000-08-24
MX9201825A (es) 1992-10-01
NZ242440A (en) 1993-10-26
JPH05139993A (ja) 1993-06-08
IL101622A (en) 1996-06-18
US5593962A (en) 1997-01-14
ZA922899B (en) 1993-10-22
AU1506692A (en) 1992-10-29
ATE194775T1 (de) 2000-08-15
GB9108634D0 (en) 1991-06-12
PT510913E (pt) 2000-12-29
IE921278A1 (en) 1992-11-04
KR100245534B1 (ko) 2000-03-02
IL101622A0 (en) 1992-12-30
JP3532580B2 (ja) 2004-05-31
GR3034414T3 (en) 2000-12-29
EP0510913A3 (en) 1993-12-15
EP0510913A2 (fr) 1992-10-28
ES2150418T3 (es) 2000-12-01
AU653395B2 (en) 1994-09-29
CY2246B1 (en) 2003-07-04
CA2066532C (fr) 2003-08-19
DE69231263T2 (de) 2000-12-21

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
LV12284A (lv) No kudras izdaliti bioaktivi produkti un tos saturosas farmaceitiskas un kosmetiskas kompozicijas
DE69019363T2 (de) Desinfizierende zusammensetzung und desinfektionsverfahren.
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
SE9802937D0 (sv) Novel compounds
DE3864210D1 (de) Pharmazeutische dosierungseinheit zur vorbeugung bzw. behandlung von klimakterischen beschwerden.
DK0510913T3 (da) Farmaceutiske sammensætninger indeholdende calcitonin
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
ATE231728T1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
DE59705525D1 (de) Kombinationspräparat enthaltend Tramadol und einen Calcium-Kanal Antagonisten
ATE130289T1 (de) 1,3-diphenyl-2-propin-1-one.
DK0495226T3 (da) Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
MX9302142A (es) Uso de 3r- y 3r,s-difenilmetoxi-1-(3,4-metileno-dioxifenetil)-piperidina y composicion que la contienen.
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
DE68905343T2 (de) Dosisform zur verabreichung von calciumantagonisten.
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
ATE86481T1 (de) Dosisform zur verabreichung von calciumantagonisten.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.